Ascend Gene & Cell Therapies Ltd. — Form D

Ascend Gene & Cell Therapies Ltd. of ALTRINCHAM, X0, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-01. The offering totals $66.6M, of which $66.6M was reported sold. Industry: Other.

Offering

• Filed: 2023-03-01
• Form: D
• Accession: 0001967249-23-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $66.6M
• Amount sold: $66.6M
• Investors: 10
• Date of first sale: 2023-02-07
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-474622

Issuer

• Name: Ascend Gene & Cell Therapies Ltd.
• CIK: 0001967249
• Entity type: Corporation
• Jurisdiction: UNITED KINGDOM
• Incorporated: 2021
• Address: 1 ASHLEY ROAD, ALTRINCHAM, X0, WA14 2DT
• Phone: 020-814-83794

Officers, directors & promoters (8)

More

• CIK 1967249 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search